Acted for Life Science REIT as Nominated Adviser, Joint Global Co-Ordinator & Joint Bookrunner on its £350m IPO and Placing, Offer for Subscription and Intermediaries Offer

November 2021

Panmure Gordon acted as Nominated Adviser, Joint Global Co-Ordinator & Joint Bookrunner on the IPO of Life Science REIT plc.

  • Offer price of 100p/£350m market cap on admission
  • Life Science REIT plans to invest in a diversified portfolio of properties across the UK in key life sciences clusters
  • Admission to Trading on the AIM market of the London Stock Exchange took place on 19 November 2021
  • Global Co-Ordinator
  • Joint Bookrunner with Jefferies
  • Upscaled oversubscribed primary raise from an initial target of £300m
  • This was the largest REIT IPO in the UK since 2016
  • 87 1×1 investor meetings, of which 48 were arranged by Panmure
  • 4 large group calls, reaching 114 separate institutions
  • In total, Panmure engaged with 77 institutions during the process

Contact Panmure Gordon

Other recent transactions like this